Join the Yale Alumni Biotech Group in a webinar that highlights the biotech industry’s response to the COVID-19 pandemic. Dr. Greg Licholai ’95 MD, Chief Medical and Information Officer at PRA Health Sciences and SOM Professor, will moderate panelists Jason Rhodes ’91, a partner at Atlas Venture, and John Evans ‘99, CEO of Beam Therapeutics, in a discussion that will look at vaccines and therapies in development and the strategies driving drug innovation. The panel will also explore the onslaught of widespread digital healthcare, and how clinical trials are surviving full shut-downs thanks to a new model of virtual drug trials.